Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL۲ and TGFβ۱/Smad۲/۳ signaling pathways

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 125

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-26-6_014

تاریخ نمایه سازی: 21 اردیبهشت 1402

چکیده مقاله:

Objective(s): Irisin was reported as a cardioprotective and anti-oxidative effector, while the effect on atrial fibrosis is unknown. The current research examined irisin’s function in atrial fibrillation (AF); atrial fibrosis brought on by Ang II can be suppressed, thus lessening the risk of developing AF. Materials and Methods: ۲۴۶ individuals were enrolled in the present case-control study. Chinese AF patients (n=۱۲۶), ۸۳ of whom were paroxysmal AF (PAF), ۴۳ patients with persistent AF (PeAF), and ۱۲۰ healthy controls. Saline or Ang II (۲.۰ mg/kg/day) was subcutaneously injected into healthy male C۵۷BL/۶ mice for four weeks. Once daily for four weeks, intraperitoneal injections of exogenous irisin (۵۰۰ g/kg/day) were administered. Results: In comparison to PAF patients and healthy controls (all P<۰.۰۵), PeAF patients had significantly higher rates of heart failure (HF), large left atrial size (LAD), hypertrophic protein B-type natriuretic peptide (BNP), malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), interleukin-۶ (IL-۶), C-terminal telopeptide of type I collagen (CTX-I), and transforming growth factor beta-۱ (TGF-β۱), while superoxide dismutase (SOD) level was low. Expression of irisin was decreased in AF patients’ serum and Ang II-infused mice. Exogenous irisin dramatically reduced apoptosis, atrial fibrosis, atrial inflammation, and the susceptibility to AF caused by Ang II. In the atrial tissue, irisin inhibited Ang II-induced fibroblast transdifferentiation, LOXL۲, TGF-β۱, collagen production, and phosphorylation of Smad۲/۳. Conclusion: The study results speculated that irisin could be a potential AF target, and it inhibited atrial fibrosis and significantly impaired increased AF susceptibility through inactivation of LOXL۲ and the TGF-β/Smad pathway.

نویسندگان

Yingbiao Wu

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Jun Luo

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Xiang Song

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Wei Gu

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Saihua Wang

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Shuwen Hao

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Zhiwu Dong

Department of Cardiology, People’s Hospital of Shache County, Xinjiang, ۸۴۴۷۰۰, China

Zhongping Ning

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis ...
  • Wu Y, Can J, Hao S, Qiang X, Ning Z. ...
  • Ma J, Chen Q, Ma S. Left atrial fibrosis in ...
  • Goldberger JJ, Arora R, Green D, Greenland P, Lee DC, ...
  • Van Wagoner DR. Paracrine signals modulate atrial epicardial progenitor cells ...
  • Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-β signaling in fibrosis. ...
  • Weiss A, Attisano L. The TGF-beta superfamily signaling pathway. Wiley ...
  • Liu Y, Lv H, Tan R, An X, Niu X-H, ...
  • Wang Q, Yu Y, Zhang P, Chen Y, Li C, ...
  • Li J, Wang S, Zhang Y-L, Bai J, Lin Q-Y, ...
  • Goette A, Arndt M, Röcken C, Spiess A, Staack T, ...
  • Magdaleno F, Trebicka J. Selective LOXL۲ inhibition: potent antifibrotic effects ...
  • Millanes-Romero A, Herranz N, Perrera V, Iturbide A, Loubat-casanovas J, ...
  • Yang J, Savvatis K, Kang JS, Fan P, Zhong H, ...
  • Yingming Z, Kangting T, Xu T, Junhong W, Jin Y, ...
  • Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, ...
  • Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin ...
  • Sanchis-Gomar F, Lippi G, Mayero S, Perez-Quilis C, Garcia-Gimenez JL. ...
  • Askari H, Rajani SF, Poorebrahim M, Haghi-Aminjan H, Raeis-Abdollahi E, ...
  • Perakakis N, Triantafyllou GA, Fernandez-Real JM, Huh JY, Park KH, ...
  • Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski ...
  • Wang HH, Zhang XW, Chen WK, Huang QK, and Chen ...
  • Colaianni G, Cinti S, Colucci S, Grano M. Irisin and ...
  • Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, ...
  • Li RL, Wu SS, Wu Y, Wang XX, Chen HY, ...
  • Aydin S, Kuloglu T, Aydin S, Eren MN, Celik A, ...
  • Peng J, Deng X, Huang W, Yu JH, Wang JX, ...
  • Tsubakihara Y, A. Moustakas A. Epithelial-mesenchymal transition and metastasis under ...
  • Yue Y, Meng K, Pu Y, Zhang X. Transforming growth ...
  • Heger J, Schulz R, Euler G. Molecular switches under TGFβ ...
  • Chen T, Li J, Liu J, Li N, Wang S, ...
  • Lu J, Shi J, Li M, Gui B, Fu R, ...
  • Lee CM, Park JW, Cho WK, Zhou Y, Han B, ...
  • Cheng T, Liu Q, Zhang R, Zhang Y, Chen J, ...
  • نمایش کامل مراجع